MAPT and Alzheimer disease: Given the immense diversity within excitatory neurons2 and the low-level expression of Camk2a in non-excitatory neurons56,57, future studies should apply neuronal class-specific approaches in mouse models of AD and tau pathology to examine cellular proteomic alterations occurring in AD pathology.